Diabetic indicators are the strongest predictors for cardiovascular disease risk in African American adults.
African Americans have higher risk of developing type 2 diabetes and cardiovascular disease (CVD) compared to other racial groups. Modifiable and non-modifiable factors play a role in the development of both diseases. This study assessed diabetes indicators in relation to other CVD risk factors taking into account confounders, among African American adults. This was a cross-sectional study in mid-life and older African Americans (≥45 years) who were recruited from the local churches. Fasting blood was collected and serum analyzed for diabetes indicators, apolipoproteins, adipokines, and lipid profile. CVD risk scores were determined using the American Heart Association and Framingham Risk Score assessments. Homeostasis Model Assessments (HOMAs) were calculated using glucose and insulin concentrations. Confounding variables were assessed by questionnaires. Data were analyzed using SPSS software, version 21, and p<0.05 was deemed significant. Descriptive statistics was used to analyze continuous variables. Frequencies and percentages were used to examine categorical variables. T-tests compared different groups while Pearson correlations provided preliminary relationships and determined variables for multiple regression analyses. A total of n=79 participants were evaluated (69% women), 59.3±9.2 years, BMI=34.7±8.3 (mean ± SD). As expected, AA men had higher fasting blood glucose than women (123.6±54.9 mg/dL versus 99.0±21.8 mg/dL), and AA women had higher insulin (11.8±13.1 mg/dL versus 7.6±6.0 mg/dL). Our study confirmed that it is likely for AA men to have significantly lower adiponectin concentrations in comparison to AA women. Based on the CVD risk assessments, men had a significantly higher risk of developing CVD than women, which has been shown previously. Apolipoproteins, adipokines, and lipid profile also negatively influenced the cardiovascular health outcomes in men. Dietary intake, probably by influencing participants' weight/adiposity, contributed to the differences in cardiovascular outcomes between men and women. In conclusion, the findings of this study revealed that diabetes and serum glucose appeared to be the leading factors for high CVD risk, on the contrary to some other indicators reported in some studies, e.g. hypertension or dyslipidemia.
Department of Nutrition, Food and Exercise Sciences, Florida State University Tallahassee, Florida, USA.
Ashley N
AN
Carter
Center on Better Health and Life for Underserved Populations, Florida State University Tallahassee, Florida, USA.
Penny A
PA
Ralston
Center on Better Health and Life for Underserved Populations, Florida State University Tallahassee, Florida, USA.
Iris
I
Young-Clark
Department of Nutrition, Food and Exercise Sciences, Florida State UniversityTallahassee, Florida, USA; Institute for Successful Longevity Affiliate, Florida State UniversityTallahassee, Florida, USA.
Jasminka Z
JZ
Ilich
African Americans; aging; blood glucose; cardiovascular disease risk; diet; type 2 diabetes
J Urban Health. 2008 Jan;85(1):11-21
17999196
Metab Syndr Relat Disord. 2010 Apr;8(2):149-56
20156068
Arh Hig Rada Toksikol. 2014 Jun;65(2):139-48
24945416
Diabetes Metab Res Rev. 2001 Mar-Apr;17(2):137-45
11307179
J Womens Health (Larchmt). 2015 Nov;24(11):859-61
26288193
J Am Coll Nutr. 2012 Apr;31(2):126-32
22855918
J Am Coll Cardiol. 2012 Dec 25;60(25):2674-82
23177296
J Acad Nutr Diet. 2012 Nov;112(11):1852-8
22995059
J Gen Intern Med. 2009 Oct;24(10):1144-8
19685264
Atherosclerosis. 2009 Apr;203(2):640-6
18829029
J Diabetes Complications. 2011 Nov-Dec;25(6):362-7
21775166
J Womens Health (Larchmt). 2011 Sep;20(9):1341-8
21732811
Clin Trials. 2012 Feb;9(1):80-9
22064686
BMC Cardiovasc Disord. 2013 Feb 22;13:9
23433085
Diabetes Care. 2009 Aug;32(8):1467-9
19435957
Metab Syndr Relat Disord. 2011 Feb;9(1):35-40
20958206
J Diabetes Complications. 2008 Jan-Feb;22(1):1-9
18191071
Obes Res. 2005 Jan;13(1):179-85
15761178
Diabetes Res Clin Pract. 2005 Mar;67(3):220-6
15713354
J Am Coll Cardiol. 2010 Sep 21;56(13):1034-41
20846602
Metabolism. 1990 Sep;39(9):931-7
2202884
Ann Epidemiol. 2004 Oct;14(9):686-95
15380800
Contemp Clin Trials. 2014 May;38(1):69-81
24685998